Literature DB >> 25524603

Sporadic late-onset nemaline myopathy in a woman with multiple myeloma successfully treated with lenalidomide/dexamethasone.

Federica Montagnese1, Simona Portaro1, Olimpia Musumeci1, Alba Migliorato1, Maurizio Moggio2, Gigliola Fagiolari2, Carmelo Rodolico1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25524603     DOI： 10.1002/mus.24545

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  8 in total

1.  IS DROPPED HEAD SYNDROME IN SPORADIC LATE-ONSET NEMALINE MYOPATHY ALWAYS UNTREATABLE?

Authors:  Simona Portaro; Rocco Salvatore Calabrò
Journal:  Innov Clin Neurosci       Date:  2020-04-01

2.  Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort.

Authors:  Mauro Monforte; Guido Primiano; Gabriella Silvestri; Massimiliano Mirabella; Marco Luigetti; Cristina Cuccagna; Enzo Ricci; Serenella Servidei; Giorgio Tasca
Journal:  J Neurol       Date:  2018-01-22       Impact factor: 4.849

Review 3.  Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases.

Authors:  Lukas J Schnitzler; Tobias Schreckenbach; Aleksandra Nadaj-Pakleza; Werner Stenzel; Elisabeth J Rushing; Philip Van Damme; Andreas Ferbert; Susanne Petri; Christian Hartmann; Antje Bornemann; Andreas Meisel; Jens A Petersen; Thomas Tousseyn; Dietmar R Thal; Jens Reimann; Peter De Jonghe; Jean-Jacques Martin; Peter Y Van den Bergh; Jörg B Schulz; Joachim Weis; Kristl G Claeys
Journal:  Orphanet J Rare Dis       Date:  2017-05-11       Impact factor: 4.123

4.  Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy.

Authors:  Rouslan Kotchetkov; Anna Dyszkiewicz-Korpanty; Vishal Kukreti
Journal:  Bone Marrow Transplant       Date:  2018-01-24       Impact factor: 5.483

5.  A case of sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance: long-term observation of neurological symptoms after autologous stem-cell transplantation.

Authors:  Takashi Ando; Takahiko Sato; Shingo Kurahashi; Yuka Kawaguchi; Yusuke Kagaya; Yukiyasu Ozawa; Satoko Hirano; Yoji Goto; Kazuo Mano; Satoshi Yokoi; Tomohiko Nakamura; Ayuka Murakami; Seiya Noda; Seigo Kimura; Jun Sone; Satoshi Kuru; Gen Sobue; Masahisa Katsuno
Journal:  Nagoya J Med Sci       Date:  2021-08       Impact factor: 1.131

6.  Case Report: Monoclonal Gammopathies of Clinical Significance-Associated Myopathy: A Case-Based Review.

Authors:  Hongbin Yu; Du He; Qing Zhang; Bei Cao; Weiping Liu; Yu Wu
Journal:  Front Oncol       Date:  2022-07-14       Impact factor: 5.738

7.  Impact of hematologic complete response in the treatment of sporadic late-onset nemaline myopathy associated with monoclonal gammopathy.

Authors:  Tânia Maia; Rui Bergantim; Henrique Costa; Jorge Pinheiro; Fernanda Trigo
Journal:  Clin Case Rep       Date:  2021-07-16

8.  Inflammatory features in sporadic late-onset nemaline myopathy are independent from monoclonal gammopathy.

Authors:  Jantima Tanboon; Akinori Uruha; Yukie Arahata; Carsten Dittmayer; Leonille Schweizer; Hans-Hilmar Goebel; Ichizo Nishino; Werner Stenzel
Journal:  Brain Pathol       Date:  2021-05       Impact factor: 6.508
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.